Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 947 across all filing types
Latest filing 2024-12-24 Regulatory Filings
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the closure of the trading window pursuant to the company's Insider Trading Code. It mentions the upcoming declaration of financial results for the quarter and nine months ended December 31, 2024, but does not contain any financial data or results itself. The document is short (1196 characters) and serves as an announcement or intimation rather than a report. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance-related notices that do not fit other categories.
2024-12-24 English
Updates
Regulatory Filings Classification · 100% confidence The document is a formal report addressed to stock exchanges (BSE and NSE) regarding a violation of the company's Insider Trading Code under SEBI (Prohibition of Insider Trading) Regulations, 2015. It details the violation by a designated person, the nature of the trade, the penalty imposed, and the actions taken by the company. The document is regulatory in nature, reporting compliance with SEBI regulations and insider trading rules. It does not contain financial statements, earnings data, or management discussion, nor is it an announcement of a report publication. It is a compliance and regulatory disclosure about insider trading violations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2024-12-24 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates by shareholders and the issuance of a 'Letter of Confirmation' in lieu of physical share certificates. It references Regulation 39(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content is an official notification to the exchanges for record-keeping and compliance purposes. It does not contain financial data, management discussion, voting results, or any report publication. It is a regulatory announcement related to shareholding records but does not fit into categories like Major Shareholding Notification (MRQ) or Director's Dealing (DIRS) since it concerns lost certificates, not share transactions or ownership threshold changes. Therefore, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous compliance and regulatory announcements that do not fit other specific categories. The document length is short (1461 characters), consistent with a regulatory filing notice rather than a full report or detailed announcement.
2024-12-18 English
Updates
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to stock exchanges providing an update on the final transfer of a property by the company. It references previous communications about the property transfer and states the completion of the final part of the transfer. The content is an update on a specific transaction related to the company's assets, not a financial report, earnings release, or regulatory certification. It does not contain financial statements or detailed financial data. The document is short (1453 characters) and serves as an announcement of a transaction update. This fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including asset transfers by way of lease for consideration.
2024-12-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the schedule of upcoming analyst/institutional investor meetings. It is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. There is no financial data, report, or detailed presentation included. The document is essentially an announcement of a meeting schedule, not a report or transcript. Given the short length (1375 characters) and the nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-12-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges informing them about the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is an announcement of planned investor meetings rather than a financial report, earnings release, or detailed presentation. The document length is only 1414 characters, indicating it is a brief notice. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-11-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.